Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system.
about
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinolRedox mechanisms in hepatic chronic wound healing and fibrogenesisLinking uric acid metabolism to diabetic complicationsA Drosophila model identifies a critical role for zinc in mineralization for kidney stone diseasePivotal role of Toll-like receptors 2 and 4, its adaptor molecule MyD88, and inflammasome complex in experimental tubule-interstitial nephritisNatural Products Improving Hyperuricemia with Hepatorenal Dual EffectsRole of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic SteatohepatitisLarge-scaled metabolic profiling of human dermal fibroblasts derived from pseudoxanthoma elasticum patients and healthy controlsAcrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophagesComparison of in vitro bioactivation of flutamide and its cyano analogue: evidence for reductive activation by human NADPH:cytochrome P450 reductase.Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review.Role of the nitro functionality in the DNA binding of 3-nitro-10-methylbenzothiazolo[3,2-a]quinolinium chloride.Xanthine oxidoreductase reference values in platelet-poor plasma and platelets in healthy volunteersThe antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection.Normalizing dysfunctional purine metabolism accelerates diabetic wound healingDiscovery of an alternate metabolic pathway for urea synthesis in adult Aedes aegypti mosquitoes.Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.Oxalate-induced activation of PKC-alpha and -delta regulates NADPH oxidase-mediated oxidative injury in renal tubular epithelial cells.Hydrogen peroxide in inflammation: messenger, guide, and assassinRedox-sensitive mechanisms underlying vascular dysfunction in heart failure.Protein undernutrition during development and oxidative impairment in the central nervous system (CNS): potential factors in the occurrence of metabolic syndrome and CNS disease.Quinone-enhanced reduction of nitric oxide by xanthine/xanthine oxidaseXanthine oxidoreductase activity in human liver disease.The in-vivo effects of sho-saiko-to, a traditional Chinese herbal medicine, on two cytochrome P450 enzymes (1A2 and 3A) and xanthine oxidase in man.Antioxidant status of neonates exposed in utero to tobacco smoke.Oxidative stress contributes to methotrexate-induced small intestinal toxicity in rats.Purification and partial characterisation of camel milk xanthine oxidoreductase.Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats.A new sensitive and quantitative chemiluminescent assay to monitor intracellular xanthine oxidase activity for rapid screening of inhibitors in living endothelial cells.Comparison ofN-Acetyltransferase-2 Enzyme Genotype-Phenotype and Xanthine Oxidase Enzyme Activity Between Swedes and Koreans
P2860
Q24652967-AF84FAFB-9094-4369-87CA-535112CC6E1AQ24656684-46AEC38C-32D2-4D0A-BCD8-663F7FB83566Q26996416-7188BBA2-4A1A-4156-AD5E-DEFA8B536099Q27309206-68E60027-AE5E-4AE3-882C-DB364E9102EFQ27311124-CC0F1B88-43DC-40F8-ACEB-151B7FCD1289Q28079286-0449C0B8-0FB8-4B75-A386-CD0B73D13CD9Q28354735-48B7E155-CA6B-441F-8D43-987D0A1B9911Q28543381-1B231422-FE26-4156-89BE-3DA8BFBF5502Q28754552-7A538404-40BC-42EA-966D-FEB58A260E70Q30010969-D4F529A4-EA60-421B-B2DD-31B04ECA2948Q30234756-7A2A15FF-4400-44B8-8805-A6C29F2C33F9Q33365148-91EBAF45-7540-4E92-894F-D9C9A0518537Q35061443-68015E57-2504-465C-BDB7-928E41AEDA07Q35997060-B95CC38D-1972-414A-BF4B-1B1BE9756F91Q36262699-D269518E-777F-4379-9437-8AC6B7528A26Q36392896-97963174-C007-4E25-9C45-3100A92E3056Q37127097-FDA8FFF4-BEA0-4FC8-931F-63205B685AA4Q37430733-04166BE3-A0F8-4920-93E8-A0C67A0FC9BBQ38022014-C74D4E8A-DF3D-424D-83BD-6720B7DE3BDDQ38383375-57FC5E81-DA03-428C-BE0F-540FDB07F72AQ38857452-BF71BB38-4927-4AA6-92F1-EB6E6E11147CQ41843292-8D32FE48-E195-465B-B1C0-4C5EEAA6E2B4Q44110708-1FD231B1-1FDD-43C6-8C64-070EAAED39F1Q44720807-4F161723-26BE-46F7-B0B6-58A3194308CAQ45148056-B21E6D7B-EF28-47F1-B668-4577693860BAQ45151584-795F9F7E-1138-4C60-B781-AF1F6F3661EEQ46605750-494DDF42-638E-4436-8EF3-59C5828EA1E6Q46847435-35998EB9-BE62-4899-A209-287F77F7458CQ53064592-3FF85C50-FE91-4DCA-8675-9E9EA5FC31E5Q58003090-F1DD94EC-B81A-4DE2-8792-D2175B42D989
P2860
Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cellular distribution, metabol ...... oxidoreductase enzyme system.
@ast
Cellular distribution, metabol ...... oxidoreductase enzyme system.
@en
Cellular distribution, metabol ...... oxidoreductase enzyme system.
@nl
type
label
Cellular distribution, metabol ...... oxidoreductase enzyme system.
@ast
Cellular distribution, metabol ...... oxidoreductase enzyme system.
@en
Cellular distribution, metabol ...... oxidoreductase enzyme system.
@nl
prefLabel
Cellular distribution, metabol ...... oxidoreductase enzyme system.
@ast
Cellular distribution, metabol ...... oxidoreductase enzyme system.
@en
Cellular distribution, metabol ...... oxidoreductase enzyme system.
@nl
P1476
Cellular distribution, metabol ...... oxidoreductase enzyme system.
@en
P304
P356
10.1016/S0009-2797(00)00203-9
P577
2000-12-01T00:00:00Z